Quantitative Systematic Strategies’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-29,003
Closed -$104K 443
2021
Q2
$104K Sell
29,003
-39,808
-58% -$140K 0.04% 435
2021
Q1
$269K Sell
68,811
-6,952
-9% -$28.7K 0.04% 494
2020
Q4
$318K Buy
75,763
+3,777
+5% +$14.6K 0.05% 472
2020
Q3
$269K Buy
71,986
+38,576
+115% +$164K 0.05% 467
2020
Q2
$146K Buy
+33,410
New +$150K 0.03% 540
2018
Q4
Sell
-38,340
Closed -$107K 944
2018
Q3
$107K Buy
38,340
+19,167
+100% +$53.8K 0.02% 567
2018
Q2
$57K Buy
+19,173
New +$45.5K 0.01% 604
2015
Q3
Sell
-70,750
Closed -$550K 647
2015
Q2
$550K Sell
70,750
-89,856
-56% -$772K 0.12% 300
2015
Q1
$1.69M Buy
160,606
+145,775
+983% +$1.99M 0.46% 62
2014
Q4
$184K Buy
+14,831
New +$225K 0.07% 302

Other funds holding BDSI

Quantitative Systematic Strategies's BDSI Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2021, closing a stake of 29,003 shares — an estimated $104K sold.

Quantitative Systematic Strategies first reported a position in BDSI in Q4 2014 and held it in 10 quarters. The position peaked at $1.69M in Q1 2015. 151 funds tracked by Wall St. Rank hold BDSI as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 29,003 BioDelivery Sciences International, Inc. shares in Q3 2021, an estimated $104K.
  • Quantitative Systematic Strategies first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 10 quarters.
  • Quantitative Systematic Strategies's BioDelivery Sciences International, Inc. position peaked at $1.69M in Q1 2015.
  • 151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.